期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
肠复安汤治疗腹泻型肠易激综合征临床观察及机制探讨 被引量:6
1
作者 舒健 董筠 马豆 《中国中医急症》 2018年第2期320-323,共4页
目的观察肠复安汤治疗腹泻型肠易激综合征(IBS-D)的临床疗效。方法将48例IBS-D患者按随机数字表法分为治疗组和对照组各24例,对照组用培菲康治疗,治疗组在对照组基础上联用肠复安汤治疗,疗程6周。对比两组临床疗效及治疗前后的近端胃容... 目的观察肠复安汤治疗腹泻型肠易激综合征(IBS-D)的临床疗效。方法将48例IBS-D患者按随机数字表法分为治疗组和对照组各24例,对照组用培菲康治疗,治疗组在对照组基础上联用肠复安汤治疗,疗程6周。对比两组临床疗效及治疗前后的近端胃容积、排空分数变化,另选20例健康者作正常组。结果治疗组脱落1例,对照脱落2例,治疗组总有效率91.30%,明显高于对照组之72.73%(P<0.01);治疗组总症状积分改善明显优于对照组(P<0.01);两组近端胃排空分数均高于正常组(P<0.05),治疗后两组排空分数下降,但与治疗前比较无统计学差异(P>0.05)。结论肠复安汤可以显著提高IBS-D治疗的临床疗效,改善患者症状,此外,还能改善患者近端胃功能。 展开更多
关键词 腹泻型易激综合征 肠复安 近端胃 胃排空
下载PDF
健脾疏肝温清并用治疗腹泻型肠易激综合征探讨 被引量:2
2
作者 舒健 董筠 《山东中医药大学学报》 2017年第1期27-28,共2页
肠易激综合征病位在肠,脾虚肝郁为本病的病机关键。脾胃虚弱,水湿內盛,肠腑湿热,肝失疏泄,气机不畅,不通则痛。本病虚实并见,寒热错杂,治以健脾疏肝、温清并用法,善用自拟肠复安随证加减,疗效显著。
关键词 腹泻型易激综合征 健脾疏肝 温清并用 肠复安
下载PDF
Mechanisms underlying feed intolerance in the critically ill: Implications for treatment 被引量:18
3
作者 Adam Deane Marianne J Chapman +3 位作者 Robert J Fraser Laura K Bryant Carly Burgstad Nam Q Nguyen 《World Journal of Gastroenterology》 SCIE CAS CSCD 2007年第29期3909-3917,共9页
Malnutrition is associated with poor outcomes in critically ill patients. Although nutritional support is yet to be proven to improve mortality in non-malnourished critically ill patients, early enteral feeding is con... Malnutrition is associated with poor outcomes in critically ill patients. Although nutritional support is yet to be proven to improve mortality in non-malnourished critically ill patients, early enteral feeding is considered best practice. However, enteral feeding is often limited by delayed gastric emptying. The best method to clinically identify delayed gastric emptying and feed intolerance is unclear. Gastric residual volume (GRV) measured at the bedside is widely used as a surrogate marker for gastric emptying, but the value of GRV measurement has recently been disputed. While the mechanisms underlying delayed gastric emptying require further investigation, recent research has given a better appreciation of the pathophysiology. A number of pharmacological strategies are available to improve the success of feeding. Recent data suggest a combination of intravenous metoclopramide and en/thromycin to be the most successful treatment, but novel drug therapies should be explored. Simpler methods to access the duodenum and more distal small bowel for feed delivery are also under investigation. This review summarises current understanding of the factors responsible for, and mechanisms underlying feed intolerance in critical illness, together with the evidence for current practices. Areas requiring further research are also highlighted. 展开更多
关键词 Critical illness Enteral nutrition Gastric emptying Gastric motility Gastrointestinal hormones METOCLOPRAMIDE ERYTHROMYCIN Prokinetic therapy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部